Document is current
Any future updates will be listed below
-
Authors
St. Paul, Michael https://orcid.org/0000-0002-5213-6415
Hendrikse, Liam D. https://orcid.org/0000-0002-0253-8512
Ying, Fan
Snow, Bryan E.
Luo, Ping https://orcid.org/0000-0002-0039-747X
Helke, Simone
Smith, Logan K.
Hilal, Arwa
Abelman, Dor D. https://orcid.org/0000-0002-6765-4733
Ramamurthy, Nisha
Nault, Hayley
Wei, Ellen N.
Gold, Matthew J.
Tobin, Chantal
Lien, Scott C.
Liu, Yi
Zhou, Wenjing
Zhang, Xin
Nguyen, Dat
Agbede, Oluwatobi
Pedersen, Stephanie
Eagles, Jenna
Saunders, Mary E.
Berger, Thorsten
Wakeham, Andrew
Scott, David S.
Ly, Dalam https://orcid.org/0000-0002-1177-0225
de Campos, Cecilia Bonolo
Liang, Guanghao
Zheng, Chunxing https://orcid.org/0000-0002-8668-0873
Wilson, Wesley V.
Masih-Khan, Esther
White, Darrell
McCurdy, Arleigh
Louzada, Martha L.
Kotb, Rami
Chu, Michael P.
Parkin, Stephen
Reece, Donna
Gul, Engin https://orcid.org/0000-0002-3922-3215
Tiedemann, Rodger https://orcid.org/0000-0003-1743-8810
Pugh, Trevor J.
Hirano, Naoto https://orcid.org/0000-0001-9070-4754
Ohashi, Pamela S.
Stewart, A. Keith
Trudel, Suzanne https://orcid.org/0000-0001-7952-6352
Mak, Tak W. https://orcid.org/0000-0001-6766-861X
- License Information
-
More Information
Article History
Received: 7 October 2025
Accepted: 30 July 2026
First Online: 16 September 2026
Ethics
Competing interests: M.S.P., L.D.H., B.E.S., P.L. and T.W.M. have filed a provisional patent related the use of PreGame and PreGame markers to identify TR γδ T cells titled ‘Methods of identifying tumour reactive immune cells’ (US63/895,410). T.W.M. reports consulting relationships with Treadwell Therapeutics, AstraZeneca, and Agios Pharmaceuticals. T.W.M. is a cofounder of, and holds equity in, Treadwell Therapeutics and TCRyption; however, this work was conducted independently and is unrelated to his roles in these companies. S.T. discloses consultancy (GSK), research funding (BMS, Genentech, GSK, Janssen, K36 therapeutics, Pfizer, Roche), honoraria (AstraZeneca, GSK, Janssen) and advisory committees (AstraZeneca, BMS, GSK, Janssen, Kite/Arcellx, Pfizer, Roche, Sanofi). The other authors declare no competing interests.
